John E. Bailey, Jr

2022

In 2022, John E. Bailey, Jr earned a total compensation of $3M as Chief Executive Officer and President at G1 Therapeutics, a 65% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$286,650
Option Awards$1,464,040
Salary$764,400
Stock Awards$491,740
Other$9,150
Total$3,015,980

Bailey received $1.5M in option awards, accounting for 49% of the total pay in 2022.

Bailey also received $286.7K in non-equity incentive plan, $764.4K in salary, $491.7K in stock awards and $9.2K in other compensation.

Rankings

In 2022, John E. Bailey, Jr's compensation ranked 1,209th out of 5,701 executives tracked by ExecPay. In other words, Bailey earned more than 78.8% of executives.

ClassificationRankingPercentile
All
1,209
out of 5,701
79th
Division
Manufacturing
582
out of 3,099
81st
Major group
Chemicals And Allied Products
211
out of 1,406
85th
Industry group
Drugs
190
out of 1,307
86th
Industry
Pharmaceutical Preparations
141
out of 953
85th

Pay ratio

John E. Bailey, Jr's Pay$3,015,980
Median Employee's Pay$243,930
Pay Ratio

12

to 1

In 2022, the annual total compensation of John E. Bailey, Jr was $3,015,980.

The annual total compensation of the median employee at G1 Therapeutics was $243,930.

The ratio of John E. Bailey, Jr's pay to the pay of median employee was therefore 12 to one.

Source: SEC filing on April 26, 2023.

Bailey's colleagues

We found two more compensation records of executives who worked with John E. Bailey, Jr at G1 Therapeutics in 2022.

2022

Jennifer Moses

G1 Therapeutics

Chief Financial Officer

2022

Mark Avagliano

G1 Therapeutics

Chief Business Officer

News

You may also like